Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
P. 059 Results From the Randomized and Open-Label Periods of the CENTAUR Trial of Sodium Phenylbutyrate and Ursodoxicoltaurine in Amyotrophic Lateral Sclerosis (ALS)
Canadian Journal of Neurological Sciences · Vol. 48 Published January 1, 2021